MedTrace Logo

Evaluating the Cologuard Test for Use in Lynch Syndrome

NCT04778566 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-11-17

No results posted yet for this study

Summary

This study is aiming to enroll 90 patients with genetically confirmed Lynch Syndrome (LS) from Geisinger's High Risk Colorectal Cancer Clinic (HRC). Upon enrollment in the study, a Cologuard test will be ordered and the results will be blinded until data analysis. Patients enrolled in the study will also undergo a colonoscopy as part of their routine HRC visit.

Conditions

Interventions

DIAGNOSTIC_TEST

Cologuard test

Cologuard is a stool-DNA screening test for detecting colon cancer

Sponsors & Collaborators

  • Geisinger Clinic

    lead OTHER

Principal Investigators

  • Rajiv Panikkar, MD · Geisinger Clinic

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-30
Primary Completion
2022-05-31
Completion
2022-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04778566 on ClinicalTrials.gov